Efficacy and Safety of OnabotulinumtoxinA in Patients with Urinary Incontinence Due to Neurogenic Detrusor Overactivity: A Randomised, Double-Blind, Placebo-Controlled Trial

Foley, 1997, Vesico-ureteric reflux in adult patients with spinal injury, Br J Urol, 79, 888, 10.1046/j.1464-410X.1997.00191.x Giannantoni, 2009, Six-year follow-up of botulinum toxin A intradetrusorial injections in patients with refractory neurogenic detrusor overactivity: clinical and urodynamic results, Eur Urol, 55, 705, 10.1016/j.eururo.2008.08.048 Hicken, 2001, Bladder management and quality of life after spinal cord injury, Am J Phys Med Rehabil, 80, 916, 10.1097/00002060-200112000-00008 Cameron, 2010, Pharmacologic therapy for the neurogenic bladder, Urol Clin North Am, 37, 495, 10.1016/j.ucl.2010.06.004 Finney, 2006, Antimuscarinic drugs in detrusor overactivity and the overactive bladder syndrome: motor or sensory actions?, BJU Int, 98, 503, 10.1111/j.1464-410X.2006.06258.x Szollar, 1996, Intravesical oxybutynin for spinal cord injury patients, Spinal Cord, 34, 284, 10.1038/sc.1996.51 Khan, 2011, Long-term effect on quality of life of repeat detrusor injections of botulinum neurotoxin-a for detrusor overactivity in patients with multiple sclerosis, J Urol, 185, 1344, 10.1016/j.juro.2010.12.002 Karsenty, 2008, Botulinum toxin A (Botox®) intradetrusor injections in adults with neurogenic detrusor overactivity/neurogenic overactive bladder: a systematic literature review, Eur Urol, 53, 275, 10.1016/j.eururo.2007.10.013 Schurch, 2005, Botulinum toxin type A is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study, J Urol, 174, 196, 10.1097/01.ju.0000162035.73977.1c Kurtzke, 1983, Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS), Neurology, 33, 1444, 10.1212/WNL.33.11.1444 Hatheway, 1994, Immunogenicity of the neurotoxins of Clostridium botulinum, 93 Stohrer, 2009, EAU guidelines on neurogenic lower urinary tract dysfunction, Eur Urol, 56, 81, 10.1016/j.eururo.2009.04.028 McGuire, 1981, Prognostic value of urodynamic testing in myelodysplastic patients, J Urol, 126, 205, 10.1016/S0022-5347(17)54449-3 Bruschini, 2006, Upper and lower urinary tract evaluation of 104 patients with myelomeningocele without adequate urological management, World J Urol, 24, 224, 10.1007/s00345-006-0087-x Athanasopoulos, 2011, The medical treatment of overactive bladder, including current and future treatments, Expert Opin Pharmacother, 12, 1041, 10.1517/14656566.2011.554399 Herbison, 2003, Effectiveness of anticholinergic drugs compared with placebo in the treatment of overactive bladder: systematic review, BMJ, 326, 841, 10.1136/bmj.326.7394.841 Schurch, 2007, Reliability and validity of the Incontinence Quality of Life questionnaire in patients with neurogenic urinary incontinence, Arch Phys Med Rehabil, 88, 646, 10.1016/j.apmr.2007.02.009 Wefer, 2010, Treatment outcomes and resource use of patients with neurogenic detrusor overactivity receiving botulinum toxin A (BOTOX) therapy in Germany, World J Urol, 28, 385, 10.1007/s00345-009-0466-1 Herschorn, 2011, Efficacy of botulinum toxin A injection for neurogenic detrusor overactivity and urinary incontinence: a randomized, double-blind trial, J Urol, 185, 2229, 10.1016/j.juro.2011.02.004 Dmochowski, 2010, Efficacy and safety of onabotulinumtoxinA for idiopathic overactive bladder: a double-blind, placebo controlled, randomized, dose ranging trial, J Urol, 184, 2416, 10.1016/j.juro.2010.08.021 Kessler, 2009, Clean intermittent self-catheterization after botulinum neurotoxin type A injections: short-term effect on quality of life, Obstet Gynecol, 113, 1046, 10.1097/AOG.0b013e3181a1f5ea Bakke, 1993, Risk factors for bacteriuria and clinical urinary tract infection in patients treated with clean intermittent catheterization, J Urol, 149, 527, 10.1016/S0022-5347(17)36136-0 Sauerwein, 2002, Urinary tract infection in patients with neurogenic bladder dysfunction, Int J Antimicrob Agents, 19, 592, 10.1016/S0924-8579(02)00114-0 Stover, 1991, Neurogenic urinary tract infection, Neurol Clin, 9, 741, 10.1016/S0733-8619(18)30277-9